Bertil Lindmark - Jan 4, 2023 Form 4 Insider Report for Galecto, Inc. (GLTO)

Role
Chief Medical Officer
Signature
/s/ Lori Firmani, attorney-in-fact
Stock symbol
GLTO
Transactions as of
Jan 4, 2023
Transactions value $
$0
Form type
4
Date filed
1/5/2023, 03:00 PM
Previous filing
Mar 23, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GLTO Stock Option (right to buy) Award $0 +115K $0.00 115K Jan 4, 2023 Common Stock 115K $1.21 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the shares subject to such option vested and became exercisable on January 4, 2024 and the remainder of the shares vest in substantially equal monthly installments for a period of 36 months thereafter, subject to the Reporting Person's continuous service to the Issuer on each such date.